Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

How To Choose Clinical Sites In China (Part 2)

This article was originally published in PharmAsia News

Executive Summary

The situation for clinical trials at the execution level in China is very different from that in developed countries, given that sites are in hospitals and must be GCP-certified by the China FDA. Due to the limitations of study professionals, site management organizations have emerged as the solution to serve the rapidly increasing number of trials in the country following health care and regulatory reforms.

Advertisement

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC089351

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel